These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 39077417)

  • 1. Cre8 Drug Eluting Stent Performance in Daily Cardiology Practice.
    Sinan UY; Serin E; Keskin-Meric B; Arat-Ozkan A
    Rev Cardiovasc Med; 2023 Feb; 24(2):53. PubMed ID: 39077417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes of real-world patients treated with an amphilimus polymer-free stent versus new generation everolimus-eluting stents.
    Panoulas VF; Latib A; Naim C; Sato K; Ielasi A; Tespili M; Godino C; Testa L; Bedogni F; Colombo A
    Catheter Cardiovasc Interv; 2015 Dec; 86(7):1168-76. PubMed ID: 26269415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized All-Comers Evaluation of a Permanent Polymer Zotarolimus-Eluting Stent Versus a Polymer-Free Amphilimus-Eluting Stent.
    Rozemeijer R; Stein M; Voskuil M; van den Bor R; Frambach P; Pereira B; Koudstaal S; Leenders GE; Timmers L; Rittersma SZ; Kraaijeveld AO; Agostoni P; Roes KC; Doevendans PA; Stella PR;
    Circulation; 2019 Jan; 139(1):67-77. PubMed ID: 30586704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-year clinical outcome of amphilimus polymer-free drug-eluting stent in diabetes mellitus patients: Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTre rEgistry).
    Colombo A; Godino C; Donahue M; Testa L; Chiarito M; Pavon AG; Colantonio R; Cappelletti A; Monello A; Magni V; Milazzo D; Parisi R; Nicolino A; Moshiri S; Fattori R; Aprigliano G; Palloshi A; Caramanno G; Montorfano M; Bedogni F; Margonato A; Briguori C
    Int J Cardiol; 2016 Jul; 214():113-20. PubMed ID: 27060269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of Polymer-Free Drug-Eluting Stents.
    Chiarito M; Sardella G; Colombo A; Briguori C; Testa L; Bedogni F; Fabbiocchi F; Paggi A; Palloshi A; Tamburino C; Margonato A; Pivato CA; Baber U; Calcagno S; Giordano A; Godino C; Stefanini GG
    Circ Cardiovasc Interv; 2019 Feb; 12(2):e007311. PubMed ID: 30767663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year clinical outcome of multicenter randomized trial comparing amphilimus - with paclitaxel-eluting stents in de novo native coronary artery lesions.
    Carrié D; Berland J; Verheye S; Hauptmann KE; Vrolix M; Musto C; Berti S; Dibié A; Maupas E; Antoniucci D; Schofer J
    Int J Cardiol; 2020 Feb; 301():50-55. PubMed ID: 31759686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of the amphilimus-eluting polymer-free stent for chronic total occlusion treatment: a multicentre experience.
    Maeremans J; Cottens D; Azzalini L; Pereira B; Godino C; Carlino M; Colombo A; Frambach P; Bellini B; Candilio L; Briguori C; Pierri A; Lamers S; Roux L; Duponselle J; Vrolix M; Dens J
    J Cardiovasc Med (Hagerstown); 2018 Oct; 19(10):564-570. PubMed ID: 30124545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials.
    Sabaté M; Räber L; Heg D; Brugaletta S; Kelbaek H; Cequier A; Ostojic M; Iñiguez A; Tüller D; Serra A; Baumbach A; von Birgelen C; Hernandez-Antolin R; Roffi M; Mainar V; Valgimigli M; Serruys PW; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2014 Jan; 7(1):55-63. PubMed ID: 24332419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter randomized trial comparing amphilimus- with paclitaxel-eluting stents in de novo native coronary artery lesions.
    Carrié D; Berland J; Verheye S; Hauptmann KE; Vrolix M; Violini R; Dibie A; Berti S; Maupas E; Antoniucci D; Schofer J
    J Am Coll Cardiol; 2012 Apr; 59(15):1371-6. PubMed ID: 22284328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Cone Flare Crush Modified-T (CFCT) stenting technique for coronary artery bifurcation lesions.
    Peverill WT; Incani A; Worthley SG; Singbal Y; Garrahy PJ; McCann AB; Cox SV; Moore PT; Lim RYY; Fetahovic T; Connors GW; Hall C; Sieg C; Camuglia AC
    Int J Cardiol Heart Vasc; 2020 Oct; 30():100643. PubMed ID: 33015315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of the ACC/AHA Lesion Classification to Predict Outcomes After Contemporary DES Treatment: Individual Patient Data Pooled Analysis From 7 Randomized Trials.
    Konigstein M; Redfors B; Zhang Z; Kotinkaduwa LN; Mintz GS; Smits PC; Serruys PW; von Birgelen C; Madhavan MV; Golomb M; Ben-Yehuda O; Mehran R; Leon MB; Stone GW
    J Am Heart Assoc; 2022 Dec; 11(24):e025275. PubMed ID: 36515253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-Year Clinical Outcomes After Implantation of Permanent-Polymer Versus Polymer-Free Stent: ReCre8 Landmark Analysis.
    van Hemert ND; Voskuil M; Rozemeijer R; Stein M; Frambach P; Pereira B; Rittersma SZ; Kraaijeveld AO; Leenders GEH; Timmers L; van der Harst P; Agostoni P; Stella PR;
    JACC Cardiovasc Interv; 2021 Nov; 14(22):2477-2486. PubMed ID: 34794654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
    Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meeting the Unmet - The Cre8 Polymer-free Drug-eluting Stents Technology: Proceedings of a satellite symposium held at EuroPCR on May 20th - 23rd 2014 in Paris.
    Mountfort K; Carrié D; Valgimigli M; Sardella G; Banai S; Romaguera R; Stella P
    Interv Cardiol; 2014 Aug; 9(3):184-189. PubMed ID: 29588800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale and design of the PARTHENOPE trial: A two-by-two factorial comparison of polymer-free vs biodegradable-polymer drug-eluting stents and personalized vs standard duration of dual antiplatelet therapy in all-comers undergoing PCI.
    Piccolo R; Calabrò P; Varricchio A; Baldi C; Napolitano G; De Simone C; Mauro C; Stabile E; Caiazzo G; Tesorio T; Boccalatte M; Tuccillo B; Bottiglieri G; Russolillo E; Di Lorenzo E; Carrara G; Cassese S; Leonardi S; Biscaglia S; Costa F; McFadden E; Heg D; Franzone A; Stefanini GG; Capodanno D; Esposito G
    Am Heart J; 2023 Nov; 265():153-160. PubMed ID: 37572785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Cre8 amphilimus-eluting stent for the treatment of coronary artery disease: safety and efficacy profile.
    Pivato CA; Leone PP; Petriello G; Sanz-Sanchez J; Chiarito M; Stefanini GG
    Expert Rev Med Devices; 2020 Apr; 17(4):267-275. PubMed ID: 32151183
    [No Abstract]   [Full Text] [Related]  

  • 17. The relation of polymer structure of stent used in patients with acute coronary syndrome revascularized by stent implantation with long-term cardiovascular events.
    Yaylak B; Polat F; Onuk T; Akyüz Ş; Çalık AN; Çetin M; Eren S; Mollaalioğlu F; Kolak Z; Durak F; Dayı ŞÜ
    Catheter Cardiovasc Interv; 2023 Dec; 102(7):1186-1197. PubMed ID: 37855201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of target lesion failure after treatment of left main, bifurcation, or chronic total occlusion lesions with ultrathin-strut drug-eluting coronary stents in the ULTRA registry.
    de Filippo O; Bruno F; Pinxterhuis TH; Gąsior M; Perl L; Gaido L; Tuttolomondo D; Greco A; Verardi R; Lo Martire G; Iannaccone M; Leone A; Liccardo G; Caglioni S; González Ferreiro R; Rodinò G; Musumeci G; Patti G; Borzillo I; Tarantini G; Wańha W; Casella B; Ploumen EH; Pyka Ł; Kornowski R; Gagnor A; Piccolo R; Roubin SR; Capodanno D; Zocca P; Conrotto F; De Ferrari GM; von Birgelen C; D'Ascenzo F;
    Catheter Cardiovasc Interv; 2023 Aug; 102(2):221-232. PubMed ID: 37232278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Durable Polymer Versus Biodegradable Polymer Drug-Eluting Stents After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome: The HOST-REDUCE-POLYTECH-ACS Trial.
    Kim HS; Kang J; Hwang D; Han JK; Yang HM; Kang HJ; Koo BK; Kim SY; Park KH; Rha SW; Shin WY; Lim HS; Park K; Park KW;
    Circulation; 2021 Mar; 143(11):1081-1091. PubMed ID: 33205662
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.